-
2025-521917-24-00
5
2026-01-21
Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
-
2025-522500-24-00
5
2026-01-20
Head and Neck squamous cell carcinoma
-
2024-519404-27-00
5
2026-01-16
IDH-mutant grade 2 or 3 astrocytoma
-
2025-520518-79-00
4
2026-01-06
Atrial Fibrillation
-
2025-521362-10-00
11
2026-01-06
Frail older patients with atrial fibrillation or venous thromboembolis
-
2022-503070-36-00
5
2025-12-23
Group B streptococcus (GBS) disease
-
2024-513586-39-00
5
2025-12-10
Prostate Cancer
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2025-521281-97-00
5
2025-12-02
Non-Small Cell Lung Cancer (NSCLC)
-
2024-517983-47-00
9
2025-11-25
Myotonic Dystrophy
-
2025-520927-26-00
5
2025-11-24
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2023-506384-34-00
7
2025-11-05
Locally advanced or metastatic urothelial carcinoma
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2024-514693-47-01
11
2025-10-28
EGFR mutated locally advanced or metastatic non-small cell lung cancer
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2025-521377-14-00
4
2025-10-06
Atrial fibrillation
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2024-517051-12-00
4
2025-09-16
Relapsed primary large B-cel lymphoma of the central nervous system
-
2025-520672-26-00
9
2025-09-16
Gastrointestinal Neoplasms
-
2025-520757-36-00
6
2025-09-15
Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
-
2023-508066-15-01
4
2025-09-01
Hormone-positive breast cancer